|
2007 Journal Article Genetic forms of primary aldosteronismStowasser, Michael, Fallo, Francesco, So, Albertina, Jeske, Yvette, Kelemen, Livia, Pilon, Catia and Gordon, Richard D. (2007). Genetic forms of primary aldosteronism. High Blood Pressure and Cardiovascular Prevention, 14 (2), 75-81. doi: 10.2165/00151642-200714020-00004 |
|
2007 Conference Publication Genetic basis of familial hyperaldosteronism type II: Further evidence of linkage at chromosome 7p22So, A, Jeske, Y., Gordon, R. D., Duffy, D., Kelemen, L., Bulmer, B. and Stowasser, M. (2007). Genetic basis of familial hyperaldosteronism type II: Further evidence of linkage at chromosome 7p22. 28th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Brisbane, Australia, 7-8 December 2006. Baltimore, USA: Lippincott Williams & Wilkins for the American Heart Association. doi: 10.1161/HYPERTENSIONAHA.107.009421 |
|
2007 Conference Publication Can liquid chromatography-tandem mass spectrometry solve the problem of aldosterone measurement?Taylor, P., Carlton, L., Franklin, M., Cooper, D., Gordon, R.D. and Stowasser, M. (2007). Can liquid chromatography-tandem mass spectrometry solve the problem of aldosterone measurement?. 28th annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Brisbane, 7-8 December, 2006. Philadelphia: Lippincott Williams & Wilkins. doi: 10.1161/HYPERTENSIONAHA.107.009421 |
|
2006 Journal Article No evidence for coding region mutations in the retinoblastoma-associated Kruppel-associated box protein gene (RBaK) causing familial hyperaldosteronism type IISo, Albertina, Jeske, Yvette W.A., Gordon, Richard D., Duffy, David, Kelemen, Livia and Stowasser, Michael (2006). No evidence for coding region mutations in the retinoblastoma-associated Kruppel-associated box protein gene (RBaK) causing familial hyperaldosteronism type II. Clinical Endocrinology, 65 (6), 829-831. doi: 10.1111/j.1365-2265.2006.02674.x |
|
2006 Journal Article Aldosterone assays: An urgent need for improvementStowasser, Michael and Gordon, Richard D. (2006). Aldosterone assays: An urgent need for improvement. Clinical Chemistry, 52 (9), 1640-1642. doi: 10.1373/clinchem.2006.073460 |
|
2006 Journal Article Monogenic mineralocorticoid hypertensionStowasser, Michael and Gordon, Richard D. (2006). Monogenic mineralocorticoid hypertension. Best Practice & Research Clinical Endocrinology & Metabolism, 20 (3), 401-420. doi: 10.1016/j.beem.2006.07.008 |
|
2006 Conference Publication Prevalence of primary aldosteronism among Chinese hypertensive patientsGong, Y., Zhu, D., Zhang,, Chen, S. L., Chu, S.X., Zhang, L.H., Stowasser, M. and Gordon, R. D. (2006). Prevalence of primary aldosteronism among Chinese hypertensive patients. 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, 15th to 19th October, 2006. Japan: International Society of Hypertension. |
|
2006 Conference Publication Lipoprotein (a) is elevated in patients with renovascular hypertension, but not in patients with primary aldosteronismKostner, K., Liu, Y., Cowley, D. and Stowasser, M. (2006). Lipoprotein (a) is elevated in patients with renovascular hypertension, but not in patients with primary aldosteronism. ISA 2006: XIV International Symposium on Atherosclerosis, Rome, Italy, 18-22 June 2006. E. Park, Shannon, Co. Clare, Ireland: Elsevier Ireland. doi: 10.1016/S1567-5688(06)81883-0 |
|
2006 Book Chapter The hypertensive accountantStowasser, Michael and Gordon, Richard D. (2006). The hypertensive accountant. Tietz's applied laboratory medicine. (pp. 175-182) edited by G. M. Scott, A. M. Gronowski, C. S. Eby and N. W. Tietz. Hoboken, N.J.: Wiley-Interscience. doi: 10.1002/9780470086087.ch23 |
|
2006 Conference Publication Further evidence of linkage at 7p22 with familial hyperaldosteronism type II and exclusion of genetic defects in the RBAK coding regionsSo, A., Jeske, Y., Gordon, R. D., Duffy, D. L., Bulmer, B. J. and Stowasser, M. (2006). Further evidence of linkage at 7p22 with familial hyperaldosteronism type II and exclusion of genetic defects in the RBAK coding regions. 27th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Melbourne, Australia, 7-9 December, 2006. Oxford, UK: Blackwell. doi: 10.1111/j.1440-1681.2006.04428.x |
|
2006 Book Chapter Primary mineralocorticoid excess syndromesEdwards, Christopher R. W. and Stowasser, Michael (2006). Primary mineralocorticoid excess syndromes. Endocrinology. (pp. 2461-2490) edited by L. J. DeGroot and J. L. Jameson. USA: Elsevier Saunders. |
|
2006 Conference Publication The expanding role of aldosterone excess in cardiovascular diseaseStowasser, M., Sharman, J., Marwick, T. and Gordon, R. (2006). The expanding role of aldosterone excess in cardiovascular disease. 21sth Scientific Meeting of the International Society of Hypertension, 5th Asian Pacific Congress of Hypertension and 29th Annual Scientific Meeting of the Japanese Society of Hypertension, Fukuoka, Japan, 15-19 October 2006. United Kingdom: Lippincott Williams & Wilkins, Ltd.. |
|
2006 Conference Publication No evidence of mutations in RBAK and PMS2 in association with familial hyperaldosteronism type IISo, A., Jeske, Y., Gordon, R. D., Duffy, D., Kelemen, L. and Stowasser, M. (2006). No evidence of mutations in RBAK and PMS2 in association with familial hyperaldosteronism type II. 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, 15 to 19 October 2006. Japan: International Society of Hypertension. |
|
2005 Journal Article Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type IStowasser, Michael, Sharman, James, Leano, Rodel, Gordon, Richard D., Ward, Gregory, Cowley, Diane and Marwick, Thomas H. (2005). Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. Journal of Clinical Endocrinology and Metabolism, 90 (9), 5070-5076. doi: 10.1210/jc.2005-0681 |
|
2005 Journal Article Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneitySo, A, Duffy, DL, Gordon, RD, Jeske, YWA, Lin-Su, K, New, MI and Stowasser, M (2005). Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity. Journal of Hypertension, 23 (8), 1477-1484. doi: 10.1097/01.hjh.0000174299.66369.26 |
|
2005 Conference Publication Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindredStowasser, M, Elphinstone, M, So, A, Jeske, Y and Gordon, R (2005). Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindred. 26th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia, Sydney Australia, Nov 24-26, 2004. OXFORD: BLACKWELL PUBLISHING. |
|
2005 Journal Article Left ventricular mass in patients with type 2 diabetes is independently associated with central but not peripheral pulse pressureSharman, James E., Fang, Zhi Y., Haluska, Brian, Stowasser, Michael, Prins, Johannes B. and Marwick, Thomas H. (2005). Left ventricular mass in patients with type 2 diabetes is independently associated with central but not peripheral pulse pressure. Diabetes Care, 28 (4), 937-939. doi: 10.2337/diacare.28.4.937 |
|
2005 Conference Publication No association between primary aldosteronism and two CYP11B2 polymorphisms in a well-characterized Australian sampleJeske, Y., So, A., Gordon, R. D., Duffy, D. and Stowasser, M. (2005). No association between primary aldosteronism and two CYP11B2 polymorphisms in a well-characterized Australian sample. 20th Annual Scientific Meeting of the American Society of Hypertension, San Francisco, U.S.A., 14-18 May 2005. New York, U.S.A.: Nature Publishing Group. doi: 10.1016/j.amjhyper.2005.03.012 |
|
2005 Conference Publication Familial hyperaldosteronism type II (FH-II): Further evidence for linkage at chromosome 7p22 but also for the predicted genetic heterogeneitySo, A., Stowasser, M., Gordon, R., Duffy, D. and Jeske, Y. (2005). Familial hyperaldosteronism type II (FH-II): Further evidence for linkage at chromosome 7p22 but also for the predicted genetic heterogeneity. The 26th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia Inc., Sydney, Australia, 24-26 November, 2004. Blackwell Scientific Publications: BLACKWELL PUBLISHING. |
|
2005 Conference Publication Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type IStowasser, Michael, Sharman, James, Leano, Rodel, Gordon, Richard, Ward, Gregory, Cowley, Diane and Marwick, Thomas (2005). Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. 20th Annual Scientific Meeting of the American Society of Hypertension, San Francisco, CA, USA, 14 - 18 May, 2005. USA: Elsevier Inc. doi: 10.1016/j.amjhyper.2005.03.648 |
